Covered recipient · General Payments record
ZACHARIAS CHASIN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$908.58
- Reported across 48 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $618.50 | 30 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $219.81 | 11 |
| ABBVIE INC. | $164.91 | 8 |
| Amgen Inc. | $124.73 | 6 |
| Exact Sciences Corporation | $51.90 | 2 |
| ITI, Inc. | $42.13 | 2 |
| GlaxoSmithKline, LLC. | $15.02 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (30)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.19 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103447226 | CMS |
| ABBVIE INC. | $18.26 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103447228 | CMS |
| ABBVIE INC. | $15.58 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103447230 | CMS |
| ABBVIE INC. | $20.41 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103447232 | CMS |
| ABBVIE INC. | $22.19 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103447234 | CMS |
| ABBVIE INC. | $23.38 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103447236 | CMS |
| ABBVIE INC. | $24.30 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103447238 | CMS |
| ABBVIE INC. | $21.60 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103447240 | CMS |
| Amgen Inc. | $23.69 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115493149 | CMS |
| Amgen Inc. | $24.90 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115493158 | CMS |
| Amgen Inc. | $17.77 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115493166 | CMS |
| Amgen Inc. | $16.20 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115493143 | CMS |
| Amgen Inc. | $22.56 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117524723 | CMS |
| Amgen Inc. | $19.61 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117524725 | CMS |
| Exact Sciences Corporation | $25.08 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114612818 | CMS |
| Exact Sciences Corporation | $26.82 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114612823 | CMS |
| GlaxoSmithKline, LLC. | $15.02 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116036128 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $21.01 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143205234 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $21.12 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143205237 | CMS |
| Novo Nordisk Inc | $21.16 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096676281 | CMS |
| Novo Nordisk Inc | $22.38 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096795943 | CMS |
| Novo Nordisk Inc | $11.22 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096902871 | CMS |
| Novo Nordisk Inc | $15.04 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096634981 | CMS |
| Novo Nordisk Inc | $21.35 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096898601 | CMS |
| Novo Nordisk Inc | $9.72 | 07/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096716334 | CMS |
| Novo Nordisk Inc | $11.55 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097290575 | CMS |
| Novo Nordisk Inc | $32.77 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097305207 | CMS |
| Novo Nordisk Inc | $20.45 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097144925 | CMS |
| Novo Nordisk Inc | $24.42 | 11/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096904873 | CMS |
| Novo Nordisk Inc | $29.75 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097198489 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.